News & Media: All

May 20, 2016

Precision's Chandra and Shafrin Address Value Frameworks in JAMA

Precision Health Economics' Amitabh Chandra and Jason Shafrin, along with author Ravider Dhawan, examine the utility of cancer value frameworks in the latest edition of the Journal of the American Medical Association (JAMA).

To read the complete article, please click here.

May 20, 2016

Precision's Sharma in The Lancet: Liberating Data to Combat NCD's

Precision's Abhishek Sharma is a featured co-author in the latest version of The Lancet Diabetes & Endocrinology-- focusing on the challenges of collecting, analysing, and using data related to non-communicable diseases (NCD's).

To read the complete article, please click here.

May 17, 2016

Peter Neumann, Leader in Health Economics and Outcomes Research, Joins Precision Health Economics as Advisor

Los Angeles, May 17, 2016 -- Precision Health Economics (PHE), a global leader in health economic research, policy, and analytics, announced today that Peter Neumann, ScD has joined PHE in the role of principal scientific advisor.

Neumann is an internationally recognized thought leader and inn ...

May 12, 2016

Precision Researchers Prominently Featured in AJMC's Special Issue on HCV

Precision Health Economics authors are prominently featured in the May 2016, Special Issue on the Hepatitis C virus, released by The American Journal of Managed Care.

Four articles published in the journal feature PHE authors, including:

  • “Does Patient Cost Sharing for HCV Drug Make Sense ...

May 11, 2016

Precision To Have Strong Presence at ISPOR's 21st Annual International Meeting, Washington DC

Precision Health Economics (PHE) researchers and scientific advisors will once again have a very strong presence at ISPOR’s 21st Annual International Meeting in Washington DC from May 21-25, 2016. PHE experts will be teaching 2 short courses, moderating and speaking at 3 issue panels, present ...

May 9, 2016

Philipson in Forbes: "Speed and Safety at the FDA"

Tomas Philipson's latest Forbes.com Op-Ed examines generic drug approvals as well as speed and safety at the FDA.

To read the complete commentary, please click here.

Apr 13, 2016

Precision's Sharma in Boston Globe: Boston Drug Pricing Dozens of Times Higher Than Overseas

Precision's Abhishek Sharma is the lead author of a new study just published in The Journal of Pharmaceutical Policy and Practice (JPPP), recently cited in the Boston Globe's STAT Pharmalot Blog. The article highlights the findings of the study illustrating that drug prices in Boston are dozens ...

Apr 12, 2016

Precision at AMCP 2016!

Come visit the Precision Health Economics team and our Precision for Value colleagues at Booth 307 at the 2016 AMCP Managed Care & Specialty Pharmacy Annual Meeting, to be held at the Moscone Convention Center, San Francisco, CA.

Look for examples of our expertise in the following presentations ...

Apr 6, 2016

Precision’s Eric Druyts to Speak at the 2016 International Liver Congress

Precision Health Economics’ Director Eric Druyts, PhD (candidate) will be attending the 2016 International Liver Congress in Barcelona, Spain, April 13 to 17 as an invited speaker presenting with the World Health Organization (WHO). Eric Druyts will be presenting on network meta-analysis as a ...

Apr 5, 2016

Tomas Philipson in Forbes: Value in Healthcare

In Tomas Philipson's latest Forbes.com op-ed, he and co-author Anupam B. Jena suggest it's time to stop scratching the surface when it comes to value in healthcare.

To read the complete commentary, please click here.

Mar 22, 2016

Precision for Medicine to Acquire ACT Oncology

Establishes leading platform for Precision Medicine Oncology Research

Bethesda, Md. and Flemington, N.J., March 22, 2016 – Precision for Medicine, part of the Precision Medicine Group, announced today that it has executed a binding agreement to acquire ACT Oncology, the leading contract res ...

Mar 17, 2016

Payer Reaction to FDA Safety Warnings- What Pharma Manufacturers Need to Know

Safety warnings on previously unknown adverse events can significantly impact a medication. Read Precision for Value's insights on what pharma manufacturers need to know:

http://www.pharmaceuticalonline.com/doc/payer-reaction-to-fda-safety-warnings-what=-pharma-manufacturers-need-to-know-0001

Mar 10, 2016

Precision's Goldman, Lakdawalla, and Philipson Challenge US Political Leaders in Wall Street Journal Open Letter

Earlier this week, Precision Health Economics founding partners Dana Goldman, Tomas Philipson and Darius Lakdawalla joined over 50 of their colleagues in an open letter published in the Wall Street Journal, challenging America's political leaders to pay more attention to the issue of chronic dis ...

Mar 4, 2016

Philipson Discusses Entitlement Reform in Forbes

In his latest Forbes.com Op-Ed, Tomas Philipson discusses entitlement reform: "Entitlement Reform: Will Cutting Medicare Raise Unfunded Liabilities In The Future?"

To read the complete article, please click here.

Feb 29, 2016

Precision at AMCP Partnership Forum

This week Precision for Value will be participating and speaking at the AMPC Partnership Forum, FDAMA 114: Improving the Exchange of Pharmacoeconomic Data which be held March 1-2, 2016 in Washington, D.C.

Feb 12, 2016

Dana Goldman's Work Cited in New York Times

Precision Health Economics co-founder Dana Goldman's work was recently cited in the New York Times: "Disparity in Life Spans of the Rich and the Poor Is Growing."

To read the complete article, please click here.

Feb 4, 2016

Precision's Lakdawalla on the BBC: 'You can't just ban Twinkies'

Precision's Darius Lakdawalla was recently interviewed for the BBC's Business Daily program, discussing the trend to ban large size sodas and other recent anti-junk food measures.

To play the interview, please click here.

Jan 19, 2016

Philipson in Forbes: Republicans and Democrats Both Wrong on Obamacare

in Tomas Philipson's latest Forbes.com Op-Ed, he illustrates how both Democrats and Republicans are both misguided in their view of the historical impact of Obamacare.

To read the editorial, please click here.

Jan 14, 2016

Precision's Renick in AMCP Q & A

Precision for Value’s President Dan Renick recently participated in a Q & A with the Academy of Managed Care Pharmacy, appearing in their newsletter. To read the complete article, please click here.

Dec 22, 2015

TPG Invests in Precision for Medicine

Leader in healthcare investing acquires stake in growing pharmaceutical services company.

Fort Worth, Texas, San Francisco and Bethesda, MD — December 22, 2015 — TPG Growth, the middle market and growth equity investment platform of TPG, a leading global private investment firm with appro ...

Dec 18, 2015

Goldman In Modern Healthcare: Drop Medicaid 'Best Price' Drug Rules

Dana Goldman's latest editorial for Modern Healthcare suggests dropping the "best price" drug rules in favor of value-based strategies.

To read the complete editorial, please click here.

Dec 7, 2015

Philipson in Forbes: "Overdosing on Protection"

Tomas Philipson's latest Forbes.com Op-Ed examines the FDA and the current product liability system.

To read the complete editorial, please click here.